| UniProt ID | AA1R_HUMAN | |
|---|---|---|
| UniProt AC | P30542 | |
| Protein Name | Adenosine receptor A1 | |
| Gene Name | ADORA1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 326 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein. |
|
| Protein Description | Receptor for adenosine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase.. | |
| Protein Sequence | MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 159 | N-linked_Glycosylation | VERAWAANGSMGEPV HHHHHHHCCCCCCCE | 35.01 | UniProtKB CARBOHYD | |
| 214 | "N6,N6-dimethyllysine" | IRKQLNKKVSASSGD HHHHHCCCCCCCCCC | 40.11 | - | |
| 214 | Methylation | IRKQLNKKVSASSGD HHHHHCCCCCCCCCC | 40.11 | - | |
| 224 | "N6,N6-dimethyllysine" | ASSGDPQKYYGKELK CCCCCHHHHHHHHHH | 45.91 | - | |
| 224 | Methylation | ASSGDPQKYYGKELK CCCCCHHHHHHHHHH | 45.91 | - | |
| 309 | S-palmitoylation | IWNDHFRCQPAPPID HHCCCCCCCCCCCCC | 5.78 | 10455026 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AA1R_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AA1R_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AA1R_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| DRD1_HUMAN | DRD1 | physical | 10890919 | |
| GNAI2_HUMAN | GNAI2 | physical | 11369591 | |
| SNF8_HUMAN | SNF8 | physical | 21988832 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| D00045 | Adenosine (JAN/USP); Adenocard (TN); Adenoscan (TN) | |||||
| D00227 | Aminophylline (USP/INN); Somophyllin (TN); Theophylline ethylenediamine (TN) | |||||
| D00371 | Theophylline (JP16); Elixophyllin (TN); Quibron-t (TN); Theo-24 (TN); Theodur G (TN); Theolair (TN); | |||||
| D00528 | Anhydrous caffeine (JP16); Caffeine (USP); Anhydrous caffeine (TN) | |||||
| D01453 | Caffeine hydrate (JP16); Caffeine monohydrate; Caffeine (TN) | |||||
| D01712 | Theophylline sodium acetate (JAN) | |||||
| D01771 | Proxyphylline (JAN/INN); Monophyllin (TN) | |||||
| D02017 | Choline theophylline (JAN); Oxtriphylline (USP); Choline theophyllinate (INN); Theophyline - choline | |||||
| D02964 | Apaxifylline (USAN/INN) | |||||
| D03051 | Bamifylline hydrochloride (USAN) | |||||
| D03898 | Doxofylline (USAN/INN); Maxivent (TN) | |||||
| D04006 | Enprofylline (USAN/INN) | |||||
| D05429 | Aminophylline hydrate (JP16) | |||||
| D05818 | Selodenoson (USAN/INN) | |||||
| D06019 | Tecadenoson (USAN/INN) | |||||
| D06103 | Theophylline (USP); Theophylline monohydrate; Accurbron (TN) | |||||
| D06104 | Theophylline sodium glycinate (USP); Asbron (TN) | |||||
| D07491 | Bamifylline (INN) | |||||
| D07603 | Caffeine citrate (USP); Cafcit (TN) | |||||
| D08989 | Rolofylline (USAN) | |||||
| D09684 | Tonapofylline (USAN/INN) | |||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...